Your account is not claimed yet. You can sign up with ORCID to claim your account.

Woo Yul Byun (Woo Y Byun)

Years Active: 2019-2023
Publications (10 Years): 3

University of Pennsylvania (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Pennsylvania

United States

BSC :: Bioengineering

Publications

Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Maciej Pietrzak, Michal Seweryn, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica Grindheim, Stephanie Hilz, David S Shames, Chris Rivard, Eric Toloza, Eric B Haura, Ciaran J McNamee, G Alexander Patterson, Saiama N Waqar, Valerie W Rusch, David P Carbone, null null
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nature medicine (2023)
Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Maciej Pietrzak, Michal Seweryn, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica Grindheim, Stephanie Hilz, David S Shames, Chris Rivard, Eric Toloza, Eric B Haura, Ciaran J McNamee, G Alexander Patterson, Saiama N Waqar, Valerie W Rusch, David P Carbone, null null
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nature medicine 28 (10) (2022)
Jeongyun Seo, Woo Yul Byun, Farid Alisafaei, Andrei Georgescu, Yoon-Suk Yi, Mina Massaro-Giordano, Vivek B Shenoy, Vivian Lee, Vatinee Y Bunya, Dan Dongeun Huh
Multiscale reverse engineering of the human ocular surface. Nature medicine 25 (8) (2019)

Woo Yul Byun.css-eqlu8i{font-size:small;padding-left:4px;} (Woo Y Byun)